The stock's rise snapped a four-day losing streak.
Private foundations providing support, resources, and advocacy for individuals and families affected by rare diseases have ...
Vertex Pharmaceuticals (VRTX) stock in focus as company secures EU backing to expand label for its cystic fibrosis therapy ...
The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...
"Living with kidney disease is a difficult challenge to navigate for patients and their families, and it can feel even more isolating and frustrating when you are living with a rare kidney disease,” ...